-
Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data.
Romero R, Conde-Agudelo A, Da Fonseca E, O'Brien JM, Cetingoz E, Creasy GW, Hassan SS, Nicolaides KH.
Am J Obstet Gynecol 2018;218:161-180. pdf -
Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data.
Romero R, Conde-Agudelo A, El-Refaie W, Rode L, Brizot ML, Cetingoz E, Serra V, Da Fonseca E, Abdelhafez MS, Tabor A, Perales A, Hassan SS, Nicolaides KH.
Ultrasound Obstet Gynecol 2017;49:303-14. pdf -
Vaginal progesterone decreases preterm birth <34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study.
Romero R, Nicolaides KH, Conde-Agudelo A, O'Brien JM, Cetingoz E, Da Fonseca E, Creasy GW, Hassan SS.
Ultrasound Obstet Gynecol 2016;48:308-17. pdf -
Prevention of preterm delivery in twin gestations (PREDICT): A multicentre randomised placebo-controlled trial on the effect of vaginal micronised progesterone.
Rode L, Klein K, Nicolaides K, Krampl-Bettelheim E, Tabor A.
Ultrasound Obstet Gynecol 2011;38:272-80. -
Progesterone and the risk of preterm birth among women with a short cervix.
Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH.
N Engl J Med 2007;357:462-9.